This study focused on a dyslipidemia- and glucose metabolic-related FADS1-FADS2 gene cluster, and showed for the first time that FADS gene confers risk to PCOS, independent of dyslipidemia and BMI. This evidence concerns the gene FADS2 and metabolic syndrome.